Cite
Does the leading pharmaceutical reform in China really solve the issue of overly expensive healthcare services? Evidence from an empirical study.
MLA
He, Yunzhen, et al. “Does the Leading Pharmaceutical Reform in China Really Solve the Issue of Overly Expensive Healthcare Services? Evidence from an Empirical Study.” PLoS ONE, vol. 13, no. 1, Jan. 2018, pp. 1–12. EBSCOhost, https://doi.org/10.1371/journal.pone.0190320.
APA
He, Y., Dou, G., Huang, Q., Zhang, X., Ye, Y., Qian, M., & Ying, X. (2018). Does the leading pharmaceutical reform in China really solve the issue of overly expensive healthcare services? Evidence from an empirical study. PLoS ONE, 13(1), 1–12. https://doi.org/10.1371/journal.pone.0190320
Chicago
He, Yunzhen, Guanshen Dou, Qiaoyun Huang, Xinyu Zhang, Yingfeng Ye, Mengcen Qian, and Xiaohua Ying. 2018. “Does the Leading Pharmaceutical Reform in China Really Solve the Issue of Overly Expensive Healthcare Services? Evidence from an Empirical Study.” PLoS ONE 13 (1): 1–12. doi:10.1371/journal.pone.0190320.